151. Harnessing DNA replication stress to target RBM10 deficiency in lung adenocarcinoma.
- Author
-
Machour, Feras E., R. Abu-Zhayia, Enas, Kamar, Joyce, Barisaac, Alma Sophia, Simon, Itamar, and Ayoub, Nabieh
- Subjects
REPLICATION fork ,LETHAL mutations ,SYNTHETIC genes ,HISTONE deacetylase ,RNA-binding proteins ,DNA replication - Abstract
The splicing factor RNA-binding motif protein 10 (RBM10) is frequently mutated in lung adenocarcinoma (LUAD) (9-25%). Most RBM10 cancer mutations are loss-of-function, correlating with increased tumorigenesis and limiting the efficacy of current LUAD targeted therapies. Remarkably, therapeutic strategies leveraging RBM10 deficiency remain unexplored. Here, we conduct a CRISPR-Cas9 synthetic lethality (SL) screen and identify ~60 RBM10 SL genes, including WEE1 kinase. WEE1 inhibition sensitizes RBM10-deficient LUAD cells in-vitro and in-vivo. Mechanistically, we identify a splicing-independent role of RBM10 in regulating DNA replication fork progression and replication stress response, which underpins RBM10-WEE1 SL. Additionally, RBM10 interacts with active DNA replication forks, relying on DNA Primase Subunit 1 (PRIM1) that synthesizes Okazaki RNA primers. Functionally, we demonstrate that RBM10 serves as an anchor for recruiting Histone Deacetylase 1 (HDAC1) to facilitate H4K16 deacetylation and R-loop homeostasis to maintain replication fork stability. Collectively, our data reveal a role of RBM10 in fine-tuning DNA replication and provide therapeutic arsenal for targeting RBM10-deficient tumors. RBM10 is the most mutated splicing factor in lung cancer. The authors reveal a non-canonical role of RBM10 in regulating DNA replication stress response. They also identify an arsenal of RBM10 synthetic lethal genes, such as WEE1, that can be therapeutically harnessed with immediate applicability. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF